160 related articles for article (PubMed ID: 35920534)
1. One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study.
Archanjo LVF; Caruso P; Nassar Junior AP
Sao Paulo Med J; 2022; 141(2):107-113. PubMed ID: 35920534
[TBL] [Abstract][Full Text] [Related]
2. Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit.
Díaz-Lagares C; Fox L; García-Roche A; Santafe M; Romera I; Barba P; Pacheco A; Roldán E; Plata-Menchaca E; Roca O; Pérez M; Valcarcel D; Ferrer R
Transplant Cell Ther; 2021 Oct; 27(10):865.e1-865.e7. PubMed ID: 34217846
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of autologous hematopoietic stem cell transplant recipients admitted to intensive care units: A multicenter study.
Nassar AP; Archanjo LVF; Ranzani OT; Zampieri FG; Salluh JIF; Cavalcanti GFR; Moreira CEN; Viana WN; Costa R; Melo UO; Roderjan CN; Correa TD; de Almeida SLS; Azevedo LCP; Maia MO; Cravo VS; Bozza FA; Caruso P; Soares M
J Crit Care; 2022 Oct; 71():154077. PubMed ID: 35636348
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D
J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780
[TBL] [Abstract][Full Text] [Related]
5. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
[TBL] [Abstract][Full Text] [Related]
6. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
Barlas T; İnci K; Aygencel G; Türkoğlu M; Tunçcan ÖG; Can F; Aydın Kaynar L; Özkurt ZN; Yeğin ZA; Yağcı M
Hematology; 2021 Dec; 26(1):328-339. PubMed ID: 33818297
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: A Retrospective, Single-Centre Study.
Lindgaard SC; Nielsen J; Lindmark A; Sengeløv H
Acta Haematol; 2016; 135(2):72-8. PubMed ID: 26512978
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
Solaiman OM; Elhassan T; Fakih RE; Mannan A; Alduhailib Z; Mahdali AA; Alzahrani H; Jamil M; Chaudhri N; Elhazmi A; Kolko M; Al-Sharif FZ; Alrbiaan A; Shaban M; Shaheen M; Salahuddin N; Alfraih FA; Altarifi AS; Hassanein M; Hosaini S; Alhashim N; Mohamed AA; Hanbali A; Aljanoubi AH; Al-Obaidi NR; Rasheed W; Maghrabi K; Almohareb F; Soubani A; Aljurf M; Ahmed SO
Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):110-119. PubMed ID: 38560973
[TBL] [Abstract][Full Text] [Related]
9. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis.
Boyacı N; Aygencel G; Turkoglu M; Yegin ZA; Acar K; Sucak GT
Hematology; 2014 Sep; 19(6):338-45. PubMed ID: 24620953
[TBL] [Abstract][Full Text] [Related]
10. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
Townsend WM; Holroyd A; Pearce R; Mackinnon S; Naik P; Goldstone AH; Linch DC; Peggs KS; Thomson KJ; Singer M; Howell DC; Morris EC
Br J Haematol; 2013 May; 161(4):578-86. PubMed ID: 23496350
[TBL] [Abstract][Full Text] [Related]
11. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
[TBL] [Abstract][Full Text] [Related]
12. Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit.
Corcía Palomo Y; Knight Asorey T; Espigado I; Martín Villén L; Garnacho Montero J
Transplant Proc; 2015 Nov; 47(9):2665-6. PubMed ID: 26680067
[TBL] [Abstract][Full Text] [Related]
13. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
Lueck C; Stadler M; Koenecke C; Hoeper MM; Dammann E; Schneider A; Kielstein JT; Ganser A; Eder M; Beutel G
Intensive Care Med; 2018 Sep; 44(9):1483-1492. PubMed ID: 30141173
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
Wu PH; Huo WX; Mo XD; Wang Y; Yan CH; Jiang H; Shen MZ; Huang XJ; An YZ
Ann Hematol; 2023 Apr; 102(4):907-916. PubMed ID: 36757444
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU.
Soubani AO; Kseibi E; Bander JJ; Klein JL; Khanchandani G; Ahmed HP; Guzman JA
Chest; 2004 Nov; 126(5):1604-11. PubMed ID: 15539734
[TBL] [Abstract][Full Text] [Related]
16. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU).
Serries M; Zenzen H; Heine M; Holderried T; Brossart P; Schwab K
Hematology; 2023 Dec; 28(1):2256198. PubMed ID: 37737158
[TBL] [Abstract][Full Text] [Related]
19. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
20. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).
Platon L; Amigues L; Ceballos P; Fegueux N; Daubin D; Besnard N; Larcher R; Landreau L; Agostini C; Machado S; Jonquet O; Klouche K
Bone Marrow Transplant; 2016 Feb; 51(2):256-61. PubMed ID: 26569092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
